Cargando…

Salvage Reconstructive Surgery During Nivolumab Therapy for a Patient With Hypopharyngeal Cancer

OBJECTIVES: Nivolumab, a fully IgG4-programmed death-1 inhibitor antibody, led to improved overall survival compared with single-agent therapy in patients with platinum-refractory recurrent head and neck cancers. In general, nivolumab is used in inoperable patients. To the best of our knowledge, the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tsushima, Nayuta, Shinozaki, Takeshi, Fujisawa, Takao, Tomioka, Toshifumi, Okano, Wataru, Ikeda, Masakazu, Tahara, Makoto, Higashino, Takuya, Hayashi, Ryuichi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2020
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7169354/ https://www.ncbi.nlm.nih.gov/pubmed/32341668 http://dx.doi.org/10.1177/1179547620908854

Ejemplares similares

A phase I, single-center, open-label study of RM-1929 photoimmunotherapy in Japanese patients with recurrent head and neck squamous cell carcinoma
por: Tahara, Makoto, et al.
Publicado: (2021)

Feasibility of salvage endoscopic resection for patients with locoregional failure after definitive radiotherapy for pharyngeal cancer
por: Satake, Hironaga, et al.
Publicado: (2015)

Eligibility for Photoimmunotherapy in Patients with Unresectable Advanced or Recurrent Head and Neck Cancer and Changes before and after Systemic Therapy
por: Shinozaki, Takeshi, et al.
Publicado: (2023)

Comparison between three age-stratified cohorts reveals poor prognosis of young patients with tongue carcinoma
por: Baba, Daisuke, et al.
Publicado: (2022)

Natural history of superficial head and neck squamous cell carcinoma under scheduled follow-up endoscopic observation with narrow band imaging: retrospective cohort study
por: Nakamura, Hiroshi, et al.
Publicado: (2016)

Real-world safety and effectiveness of nivolumab for recurrent or metastatic head and neck cancer in Japan: a post-marketing surveillance
por: Tahara, Makoto, et al.
Publicado: (2021)

Outcomes of Anterolateral Thigh Flap Reconstruction for Salvage Laryngopharyngectomy for Hypopharyngeal Cancer after Concurrent Chemoradiotherapy
por: Chen, Wei F., et al.
Publicado: (2013)

Salvage surgery in post-chemoradiation laryngeal and hypopharyngeal carcinoma: outcome and review
por: PUTTEN, L., et al.
Publicado: (2015)

Optimal timing for salvage surgery after definitive radiotherapy in hypopharyngeal cancer
por: Chun, Seok-Joo, et al.
Publicado: (2018)

Salvage transoral videolaryngoscopic surgery for post‐irradiation recurrence of hypopharyngeal carcinoma
por: Sakai, Akihiro, et al.
Publicado: (2023)

Predictive Value of Cetuximab-Induced Skin Toxicity in Recurrent or Metastatic Squamous Cell Carcinoma of the Head and NECK
por: Uozumi, Shinya, et al.
Publicado: (2018)

Different Response to Nivolumab in a Patient with Synchronous Double Primary Carcinomas of Hypopharyngeal Cancer and Non-Small-Cell Lung Cancer
por: Yamaguchi, Teppei, et al.
Publicado: (2017)

Paclitaxel Plus Cetuximab as 1st Line Chemotherapy in Platinum-Based Chemoradiotherapy-Refractory Patients With Squamous Cell Carcinoma of the Head and Neck
por: Enokida, Tomohiro, et al.
Publicado: (2018)

Combination Treatment With Paclitaxel, Carboplatin, and Cetuximab (PCE) as First-Line Treatment in Patients With Recurrent and/or Metastatic Nasopharyngeal Carcinoma
por: Ueda, Yuri, et al.
Publicado: (2020)

Remarkable response of nivolumab‐refractory lung cancer to salvage chemotherapy
por: Ogawara, Daiki, et al.
Publicado: (2017)

The Use of Short Segment Free Jejunal Transfer as Salvage Surgery for Cervical Esophageal and Hypopharyngeal Cancer
por: Mayanagi, Shuhei, et al.
Publicado: (2013)

Posttreatment Non-Improved Vocal Cord Mobility Indicates the Need of Salvage Surgery for Hypopharyngeal Carcinomas
por: He, Yu-qin, et al.
Publicado: (2021)

Stripped Mesenteric Flap: A Novel Option for Preventing Anastomotic Leakage in Circumferential Pharyngeal Reconstruction
por: Fukunaga, Yutaka, et al.
Publicado: (2018)

Oncologic and Functional Outcomes After Primary and Salvage Laryngopharyngoesophagectomy With Gastric Pull-Up Reconstruction for Locally Advanced Hypopharyngeal Squamous Cell Carcinoma
por: Meulemans, Jeroen, et al.
Publicado: (2019)

Planned drug holidays during treatment with lenvatinib for radioiodine-refractory differentiated thyroid cancer: a retrospective study
por: Matsuyama, Chihiro, et al.
Publicado: (2023)

A case of multiple metastatic sarcomatoid renal cell carcinoma with complete response to nivolumab
por: Tomioka, Masayuki, et al.
Publicado: (2021)

A Case of Advanced Gastric Cancer with Peritoneal Metastasis Treated Successfully with Nivolumab
por: Tazawa, Hirofumi, et al.
Publicado: (2019)

Salvage vs. Primary Total Laryngectomy in Patients with Locally Advanced Laryngeal or Hypopharyngeal Carcinoma: Oncologic Outcomes and Their Predictive Factors
por: Shoushtari, Shahin Tahan, et al.
Publicado: (2023)

Complications and oncological outcomes after salvage surgery for recurrent and residual hypopharyngeal squamous cell carcinoma: a retrospective cohort study
por: Zhang, Ye, et al.
Publicado: (2022)

A case of advanced hypopharyngeal cervical esophageal cancer treated by curative resection with management of tracheoesophageal fistula
por: Ohno, Shinya, et al.
Publicado: (2023)

Therapeutic Responses to Combination Nivolumab and Temozolomide as Salvage Therapy for Metastatic Melanoma: A Case Series
por: Goodman, Rachel S, et al.
Publicado: (2023)

T-shaped Pectoralis Major Musculocutaneous Flap for Reconstruction of an Extensive Circumferential Pharyngeal Defect
por: Miyamoto, Shimpei, et al.
Publicado: (2014)

Impact of lenvatinib-induced proteinuria and renal dysfunction in patients with thyroid cancer
por: Shibutani, Yuma, et al.
Publicado: (2023)

Pepsin and Laryngeal and Hypopharyngeal Carcinomas
por: Yin, Cheng-Yi, et al.
Publicado: (2021)

Bile reflux and hypopharyngeal cancer
por: Vageli, Dimitra P., et al.
Publicado: (2021)

Developing a single strain for in vitro salvage synthesis of NAD(+) at high temperatures and its potential for bioconversion
por: Taniguchi, Hironori, et al.
Publicado: (2019)

Treatment outcomes of definitive chemoradiotherapy for patients with hypopharyngeal cancer
por: Nakahara, Rie, et al.
Publicado: (2012)

Phase II Study of Nivolumab and Salvage Nivolumab/Ipilimumab in Treatment-Naive Patients With Advanced Clear Cell Renal Cell Carcinoma (HCRN GU16-260-Cohort A)
por: Atkins, Michael B., et al.
Publicado: (2022)

Boerhaave syndrome due to hypopharyngeal stenosis associated with chemoradiotherapy for hypopharyngeal cancer: a case report
por: Tanaka, Hideharu, et al.
Publicado: (2018)

Nivolumab as salvage treatment in a patient with HIV-related relapsed/refractory Hodgkin lymphoma and liver failure with encephalopathy
por: Sandoval-Sus, Jose D., et al.
Publicado: (2017)

Prognostic Biomarkers of Salvage Chemotherapy Following Nivolumab Treatment for Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma
por: Wakasaki, Takahiro, et al.
Publicado: (2020)

Nivolumab-induced Acute Fibrinous and Organizing Pneumonia (AFOP)
por: Ishiwata, Tsukasa, et al.
Publicado: (2017)

Free posterior tibial flap reconstruction for hypopharyngeal squamous cell carcinoma
por: Chen, Fei, et al.
Publicado: (2014)

TYPE II HYPOPHARYNGEAL DEFECT RECONSTRUCTION - A SINGLE INSTITUTION EXPERIENCE
por: Pegan, Alan, et al.
Publicado: (2018)

Phase II study of nivolumab and salvage nivolumab/ipilimumab in treatment-naïve patients with advanced non-clear cell renal cell carcinoma (HCRN GU16-260-Cohort B)
por: Atkins, Michael B, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_vl91gb9do1vomtagccag1g5mj7